Better Therapeutics, a prescription digital therapeutics company, announced a private placement of the company's common stock, which garnered gross proceeds of approximately $6.5 million.
Officers and directors of the company participated in the placement, which is expected to close on or around April 10.
Better Therapeutics was among the many digital health companies that went public by merging...
Better Therapeutics, a prescription digital therapeutics platform, has laid off approximately 35% of its workforce due to a cost reduction initiative, according to a U.S. Securities and Exchange Commission filing on Friday.
The company provides cognitive behavioral therapy to address diabetes, hypertension and other cardiometabolic diseases.
Per the SEC filing, the company expects to incur...
Boston-based provider Mass General Brigham is teaming up with DTx company Better Therapeutics on a real-world data study collaboration focused on diabetes. Specifically, the organizations will be looking at the effectiveness and utilization of Better Therapeutic's prescription digital therapeutic on delivering virtual therapies to patients with Type 2 diabetes.
Patients enrolled in the study...
Calibrate, a virtual program for losing weight, announced Wednesday it has raised $100 million in Series B funding.
The round was led by new investors Founders Fund and Tiger Global, with participation from Optum Ventures and existing investors Forerunner Ventures, Threshold Ventures and Redesign Health.
Calibrate plans to use the capital to expand its telehealth platform and build its...
Better Therapeutics, a nutritional cognitive behavioral therapy digital therapeutics company, announced plans today to go public by merging with special purpose acquisition company Mountain Crest Acquisition Corp II.
The deal is expected to close this summer, subject to stockholder approval, and will raise $113 million for the combined company. It includes a $50 million private investment in...
Wearables, services perform well for Apple. While iPhone sales and overall Q2 revenue were down in 2019, the company was fairly optimistic on its most recent earnings report due to substantial growth among its wearables, iPads and services businesses.
In terms of healthcare, CEO Tim Cook noted during the investors’ call that the past quarter included the rollout of the Apple Watch Series 4’s ECG...
A study published last month in JMIR Cardio demonstrated significant systolic and diastolic blood pressure reductions in hypertension patients who received a mobile app-based behavior change intervention.
The investigation examined Better Therapeutics’ candidate digital therapeutic for cardiovascular disease, a daily-use app that encourages users to set and record their progress toward...
San Francisco-based FareWell is changing its name to Better Therapeutics, a rebranding that reflects the company’s shift in focus from weight loss and disease prevention to digital therapeutics to treat chronic diseases. To punctuate that shift, Better Therapeutics is announcing the name change on the same day as the publication of a study in the Journal of Medical Internet Research that...
